PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A） | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder	Recruiting	Phase 4	2026-02-12		NCT07406139

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Children's Hospital of Chongqing Medical University	24
First Affiliated Hospital of Guangxi Medical University	96
Institute of Hematology & Blood Diseases Hospital, China	285
North China University of Science and Technology	7
The First Affiliated Hospital of Xiamen University	107
The Second Affiliated Hospital of Kunming Medical University	33
The Second People's Hospital of Anhui Province	6
Union Hospital, Affiliated to Fujian Medical University	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Institute of haematology and Blood diseases hospital	Tianjin	China	2